Study links blood pressure drugs to cancer

A range of drugs widely used to treat high blood pressure and heart failure may be linked to cancer, study results suggest.

Use of angiotensin receptor blockers (ARB) was associated with a "modestly increased risk" of new cancer diagnosis, said researchers.

Although the likelihood of actually developing cancer while taking one of the drugs was small, one expert called the findings "disturbing and provocative".

Others urged patients on the potentially life-saving drugs not to stop taking their medications.

ARBs are commonly prescribed for the treatment of high blood pressure, heart failure, and kidney damage due to diabetes.

They work by blocking the activity of a hormone that prevents blood vessels from dilating, thus raising blood pressure.

Although the drugs are considered safe, one previous trial reported a significant increase in fatal cancers in patients treated with the ARB candesartan.

To carry out the new investigation, US researchers pooled together and analysed all the previously published data from ARB studies prior to November 2009.

They also looked at new data from five trials involving 61,590 patients, and trends relating to lung, prostate and breast cancers, and cancer deaths. Part of the analysis involved deaths among 93,515 patients who took part in eight trials.

More than 85% of the patients were taking one type of ARB, telmisartan.

The findings showed that 7.2% of patients taking ARBs were diagnosed with a new cancer over a period of four years compared with 6% of patients not treated with the drugs.

Although the result was significant, the authors led by Dr Ilke Sipahi, from Case Western Reserve University School of Medicine in Cleveland, Ohio, stressed that it should be seen in context.

"The finding of a 1.2% increase in absolute cancer risk over an average of four years needs to be interpreted in view of the estimated 41% background lifetime cancer risk," they wrote in The Lancet Oncology medical journal.

Among specific solid organ cancers examined, only the risk of lung cancer was significantly increased in patients taking ARBs. Their risk was raised from 0.7% to 0.9%.

No significant excess in cancer deaths was found, although the researchers said this may only have been because of the short follow-up time.

In an accompanying comment article, Dr Steven Nissen, from the Cleveland Clinic in Cleveland, said: "The meta-analysis... by Sipahi and colleagues is disturbing and provocative, raising crucial drug safety questions for practitioners and the regulatory community."

But two British experts said the research should be viewed with caution.

Martin Ledwick, head information nurse at Cancer Research UK, said: "At the moment there isn't enough evidence to draw any firm conclusions about how blood pressure drugs might affect cancer risk and this will need further investigation.

"People shouldn't stop taking these drugs on the basis of this research, if they're concerned they should speak to their GP."

Dr Tim Chico, from the Medical Research Council Centre for Developmental and Biomedical Genetics at the University of Sheffield, said: "This study does not prove that these drugs cause cancer, although it is certain that lowering blood pressure save lives by preventing strokes and heart attacks. If people taking medication are worried about possible side effects, I recommend they discuss this with their GP."

Boehringer Ingelheim manufactures the angiotensin receptor blocker (ARB) telmisartan under the brand name Micardis.

The company's corporate senior vice president medicine Professor Dr Klaus Dugi said: "Our research efforts have centred on the need to protect patients, especially older patients from cardiovascular risks such as myocardial infarction or stroke. Telmisartan fulfils this need. It is the only ARB which has cardiovascular protection in its label and has become a valuable treatment option in the management of hypertension and cardiovascular risk.

"Doctors and patients appreciate its excellent safety profile.

"In pre-clinical trials, clinical trials and day-to-day patient exposure with telmisartan, we have not seen any significant finding related to malignancies. Patients should consult with their physicians before making any decision regarding their antihypertensive therapy."

PROMOTED VIDEO
Life and Style
ebookNow available in paperback
ebooks
ebookPart of The Independent’s new eBook series The Great Composers
Latest stories from i100
Have you tried new the Independent Digital Edition apps?

ES Rentals

    Independent Dating
    and  

    By clicking 'Search' you
    are agreeing to our
    Terms of Use.

    iJobs Job Widget
    iJobs General

    Tradewind Recruitment: PMLD Teacher

    Negotiable: Tradewind Recruitment: PMLD Teacher A specialist primary school i...

    Recruitment Genius: Online Media Sales Trainee

    £15000 - £30000 per annum: Recruitment Genius: Now our rapidly expanding and A...

    Recruitment Genius: Public House Manager / Management Couples

    £15000 - £20000 per annum: Recruitment Genius: Are you passionate about great ...

    Recruitment Genius: Production Planner

    £20000 - £30000 per annum: Recruitment Genius: This fast growing reinforcing s...

    Day In a Page

    As in 1942, Germany must show restraint over Greece

    As in 1942, Germany must show restraint over Greece

    Mussolini tried to warn his ally of the danger of bringing the country to its knees. So should we, says Patrick Cockburn
    Britain's widening poverty gap should be causing outrage at the start of the election campaign

    The short stroll that should be our walk of shame

    Courting the global elite has failed to benefit Britain, as the vast disparity in wealth on display in the capital shows
    Homeless Veterans appeal: The rise of the working poor: when having a job cannot prevent poverty

    Homeless Veterans appeal

    The rise of the working poor: when having a job cannot prevent poverty
    Prince Charles the saviour of the nation? A new book highlights concerns about how political he will be when he eventually becomes king

    Prince Charles the saviour of the nation?

    A new book highlights concerns about how political he will be when he eventually becomes king
    How books can defeat Isis: Patrick Cockburn was able to update his agenda-setting 'The Rise of Islamic State' while under attack in Baghdad

    How books can defeat Isis

    Patrick Cockburn was able to update his agenda-setting 'The Rise of Islamic State' while under attack in Baghdad
    Judith Hackitt: The myths of elf 'n' safety

    Judith Hackitt: The myths of elf 'n' safety

    She may be in charge of minimising our risks of injury, but the chair of the Health and Safety Executive still wants children to be able to hurt themselves
    The open loathing between Barack Obama and Benjamin Netanyahu just got worse

    The open loathing between Obama and Netanyahu just got worse

    The Israeli PM's relationship with the Obama has always been chilly, but going over the President's head on Iran will do him no favours, says Rupert Cornwell
    French chefs get 'le huff' as nation slips down global cuisine rankings

    French chefs get 'le huff' as nation slips down global cuisine rankings

    Fury at British best restaurants survey sees French magazine produce a rival list
    Star choreographer Matthew Bourne gives young carers a chance to perform at Sadler's Wells

    Young carers to make dance debut

    What happened when superstar choreographer Matthew Bourne encouraged 27 teenage carers to think about themselves for once?
    Design Council's 70th anniversary: Four of the most intriguing prototypes from Ones to Watch

    Design Council's 70th anniversary

    Four of the most intriguing prototypes from Ones to Watch
    Dame Harriet Walter: The actress on learning what it is to age, plastic surgery, and her unease at being honoured by the establishment

    Dame Harriet Walter interview

    The actress on learning what it is to age, plastic surgery, and her unease at being honoured by the establishment
    Art should not be a slave to the ideas driving it

    Art should not be a slave to the ideas driving it

    Critics of Tom Stoppard's new play seem to agree that cerebral can never trump character, says DJ Taylor
    Bill Granger recipes: Our chef's winter salads will make you feel energised through February

    Bill Granger's winter salads

    Salads aren't just a bit on the side, says our chef - their crunch, colour and natural goodness are perfect for a midwinter pick-me-up
    England vs Wales: Cool head George Ford ready to put out dragon fire

    George Ford: Cool head ready to put out dragon fire

    No 10’s calmness under pressure will be key for England in Cardiff
    Michael Calvin: Time for Old Firm to put aside bigotry and forge new links

    Michael Calvin's Last Word

    Time for Old Firm to put aside bigotry and forge new links